This Sources Sought opportunity was posted on September 5, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

MEDICAL REAGENTS AND MICROBIOLOGICAL MEDIA PLATES

Closed

DLATSP18SS0002Federal

Submission Closed09/25/2017, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency Troop Support Pacific is conducting market research to identify qualified local sources for the procurement and drop shipment of Class VIII medical supplies to the United States Naval Hospital in Okinawa, Japan. The requirement specifically involves providing SYSMEX Hematology Reagents on an as-needed basis and Microbiological Media Plates according to a fixed annual delivery schedule. The government intends to utilize a Firm-Fixed Priced Indefinite Delivery, Indefinite Quantity contract under NAICS code 325412. The period of performance consists of a 12-month base ordering period starting November 30, 2017, with two additional 12-month option periods. Interested companies must be registered in the System for Award Management database and submit a response by September 25, 2017. Submissions must include company registration details, DUNS and NCAGE numbers, and a capabilities statement demonstrating relevant past performance.

General Info

Agency

N/A

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

United States Naval Hospital (USNH) Okinawa Laboratory Department Camp Foster, Building 960, Tarawa Rd. Ginowan City Okinaw, OKINAWA, JPN

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhaseClosed

PostedAug 22

Sources Sought

Notice updatedSep 5

Response deadline changed from Sep 6, 2017 to Sep 25, 2017. The notice description changed.

Response DeadlineSep 25

Deadline has passed

Submission Closed

09/25/2017, 09:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

Contacts2 people available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Khristina Matthews-SandovalCONTRACTING OFFICER

contact@example.gov

+1 (555) 000-0000

Ayako NakagawaPurchasing & Contract Assistant

contact@example.gov

+1 (555) 000-0000

Full Description

SOURCES SOUGHT NOTICE DLA Troop Support Pacific Reference Number DLATSP-18-SS-0002 CLASS VIII; MEDICAL REAGENTS AND MICROBIOLOGICAL MEDIA PLATE DROP SHIPMENTS FOR THE LABORATORY DEPARTMENT AT THE UNITED STATES NAVAL HOSPITAL, CAMP FOSTER, OKINAWA, JAPAN DLA Troop Support Pacific Location: Okinawa, Japan Requirement: The Defense Logistics Agency (DLA) Troop Support Pacific is issuing this Sources Sought Notice as a means of conducting market research to identify local sources capable and interested in fulfilling a requirement for the procurement and drop shipment deliveries of CLASS VIII, Medical supplies, materials and equipment items in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The Contractor shall provide SYSMEX Hematology Reagents and Microbiological Media Plate medical supply items to the USNH, located in Okinawa, Japan. The Contractor will be required to fulfill SYSMEX Hematology Reagent orders on an "as-needed" basis. Media Plate deliveries will be ordered and must be delivered based upon a fixed, annual Delivery Schedule. Period of Performance: The base ordering period will extend over a 12-month period, commencing on November 30, 2017 and extending through November 29, 2018, followed by two (2) 12-month period additional ordering periods. Place of Performance: The work to be performed and/or supplies to be delivered under this contract shall be at the designated delivery location. The primary delivery location is as follows: United States Naval Hospital (USNH) Okinawa Laboratory Department Camp Foster, Building 960, Tarawa Rd. Ginowan City Okinawa, Japan 901-2221 Point of Contact (POC): Mr. Minoru Oshiro Telephone: 098-971-7418 ***Please see the DRAFT Statement of Work for additional details. Contract Type: DLA Troop Support Pacific contemplates a Firm-Fixed Priced Indefinite Delivery, Indefinite Quantity type contract. NAICS Selection: The applicable North American Industry Classification System (NAICS) code is 325412; Pharmaceutical Preparation Manufacturing. This United States (U.S.) industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. ***All interested sources who consider themselves qualified and capable in providing the medical supplies described within this Notice are invited to submit a response to this Sources Sought Notice via email to Ayako.Nakagawa.jpn@DLA.mil and Khristina.Matthews-Sandoval@DLA.mil. 1:00 p.m. Japan Standard Time (JST) on Monday, September 25, 2017. Responses shall include the following: 1) Legal and Registered Name of Company; 2) Legal and Registered Company Address; 3) Company's Duns and Bradstreet Number (DUNS) Number (used when registering in the System for Award Management (SAM) Database; 4) Company's National Commercial and Government Entity (NCAGE) Code Number; 5) Point of Contact, to include telephone number and email address; and 6) Brief Capabilities Statement of Company (Statements should describe recent and relative past performance to the NAICS code identified within this notice). THIS SOURCES SOUGHT ANNOUNCEMENT IS FOR INFORMATIONAL AND MARKET RESEARCH PURPOSES ONLY. THIS NOTICE DOES NOT CONSTITUTE A SOLICITATION AND SHALL NOT BE CONSTRUED AS A COMMITMENT BY THE U.S. GOVERNMENT. THE U.S. GOVERNMENT IS UNDER NO OBLIGATION TO AWARD A CONTRACT AS A RESULT OF THIS ANNOUNCEMENT. ALL INFORMATION SUBMITTED IN RESPONSE TO THIS ANNOUNCEMENT IS VOLUNTARY. ADDITIONAL NOTES FOR INTERESTED SOURCES All companies doing business with the Federal Government must be registered in the System for Award Management (SAM) Database. The website for registration is www.sam.gov. Interested sources seeking additional information relating to the announcement are asked to review the following websites: - 1. NAICS: http://www.census.gov/ - 2. SAM Database: https://www.sam.gov/ Questions regarding this Notice shall be directed to the following Government Point of Contact: Khristina Matthews-Sandoval Contracting Officer DLA Troop Support Pacific; Okinawa, Japan Mobile: 080-8592-2456 or 098-911-5111; Ext. 637-1104 Email: Khristina.Matthews-Sandoval@DLA.Mil ****Local (Okinawan) Companies must dial (098) 911-5111, wait for the dial tone and then dial 637-1104 to be connected. If your company requires assistance in Japanese, please contact: Ayako Nakagawa MLC Purchasing and Contract Assistant DLA Troop Support Pacific; Okinawa, Japan Email: Ayako.Nakagawa.jpn@DLA.mil **** Local (Okinawan) Companies must dial (098) 911-5111, wait for the dial tone and then dial 637-1118 to be connected.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS